@jmacpher Kudos to Cytiva. This is huge! One quick question. Can the paper be eliminated safely before products go into the environmentally monitored quarantined manufacturing materials storage area?
Introducing IRO®, the new standard in CGT #manufacturing technology.
Manufacturing remains a critical barrier to scaling CGTs, limiting the clinical and commercial impact of this lifesaving new class of therapies.
That’s why we developed IRO®.
➡️ https://t.co/sXmyr9zVcj
Today we introduce the CellSeal® CryoCase™ closed-system rigid container at the @ISCTglobal Conference in Vancouver.
Read the press release for more details.
https://t.co/t4sVynKfhe
Did you catch this @BioProcessIntl piece by Brent Morse and Alicja Fiedorowicz? "Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control."
Read now, here! https://t.co/JYPjIyhbxT
@GalapagosGlobal is... "teaming up with the largest blood supply network in the U.S. to help realize its decentralized production ambitions for CAR-T therapies on a national scale."
"Late Wednesday, Galapagos unveiled a new pact with @BCAbloodcenters (BCA), gaining access to the collection and donation network’s 50-plus community blood centers across 43 states to assist with manufacturing of Galapagos’ clinical CAR-T programs in hematology/oncology."
#decentralizedmanufacturing #celltherapy @BCACellTherapy
@harisvromas@adamfeuerstein@BrianSkorney One could imagine a scenario where a company might have the processes and patients lined up to almost immediately do collections but perhaps there are complexities which are not contemplated in this imaginary world of preparedness.
@darkhorsecagt Also super curious that the Pegasi data suggest 15% growth in market share for Allo but the VOC data anticipates no material change in transport/logistics costs over 5 years. That's a curious disconnect.
@darkhorsecagt These wereare great graphics. Thank you! Trying to understand the auto/allo graph. May we also assume this is from data "as of 2022"? If so, is there any material difference between this and the actual data on the auto/allo breakdown as of the end of 2023?
NY Governor Releases Request for Proposals for State-of-the-Art Cell and Gene Therapy Hub on Long Island.
More Than $150M Available Builds on Governor’s Commitment to Boosting Fast Growing Sectors Like Life Sciences — Including State Commitment to Establishing Two Cell and Gene Therapy Hubs
New Hub Will Help to Position New York State as National Leader in Cell and Gene Therapies
https://t.co/uIF3buHzzM